CCL2 and systemic sclerosis: Our findings show that the chemokine CCL2 (secreted by monocytes, macrophages, fibroblasts, and endothelial cells) circulates at higher levels in the plasma of SSc‐ILD patients, thus supporting the importance of inflammation contributing to ILD development.